Australia's Biota to merge with USA's Nabi - Pharma Times
Updated NewsAustralia's Biota to merge with USA's NabiPharma TimesBiota Pharmaceuticals will have three royalty generating products on its books: the antivirals Relenza (zanamivir) and Inavir, and potentially the phosphate binder PhosLyra (calcium acetate).